Tata Chemicals vs Privi Speciality Chemicals: share price & financials comparison
NSE: TATACHEM vs PRIVISCL · Chemicals · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Tata Chemicals vs Privi Speciality Chemicals at a glance
Tata Chemicals (TATACHEM) has a market capitalisation of ₹15,450 Cr, against ₹13,198 Cr for Privi Speciality Chemicals (PRIVISCL). Over the past year Privi Speciality Chemicals has returned +13.2%, compared with -32.1% for Tata Chemicals. Privi Speciality Chemicals earns a higher return on equity (17.7% vs -10.8%). Tata Chemicals comes out ahead on valuation and financial health. Privi Speciality Chemicals comes out ahead on size, profitability, growth, momentum and technicals. Across the scored metrics below, Tata Chemicals leads on 3 and Privi Speciality Chemicals on 12. On StoxGud's 10-point checklist, Tata Chemicals scores 3/10 and Privi Speciality Chemicals scores 8/10.
| Metric | Tata Chemicals | Privi Speciality Chemicals |
|---|---|---|
| Size | ||
| Market cap | ₹15,450 Cr | ₹13,198 Cr |
| Revenue (latest FY) | ₹14,584 Cr | ₹2,564 Cr |
| Net profit (latest FY) | ₹-1,896 Cr | ₹0 Cr |
| Valuation | ||
| P/E | — | 47.3 |
| P/B | 0.70 | 8.38 |
| Dividend yield | 1.81% | 0.15% |
| Profitability | ||
| Return on equity | -10.8% | 17.7% |
| Net profit margin | -15.3% | 10.1% |
| Operating margin | 10.1% | 24.8% |
| Growth | ||
| Revenue growth (YoY) | +7.7% | +12.0% |
| Net profit growth (YoY) | -258.4% | — |
| Revenue CAGR (multi-year) | +7.4% | +15.0% |
| Financial health | ||
| Debt to equity | 0.35 | 0.62 |
| Momentum | ||
| 1-month return | -3.8% | -0.3% |
| 1-year return | -32.1% | +13.2% |
| 3-year CAGR | -13.8% | +38.0% |
| 5-year CAGR | -8.4% | +15.3% |
| 10-year CAGR | — | +21.7% |
| Distance from 52W high | -30.6% | -9.9% |
| Technicals | ||
| RSI (14) | 66 | 56 |
| Price vs 200-day avg | -11.4% | +2.9% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Tata Chemicals | Privi Speciality Chemicals |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✗ | ✓ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✓ |
| Positive 1-year return | ✗ | ✓ |
| Return on equity above 15% | ✗ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✗ | ✗ |
| Score | 3/10 | 8/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Tata Chemicals or Privi Speciality Chemicals?
Tata Chemicals has a market cap of ₹15,450 Cr and Privi Speciality Chemicals has a market cap of ₹13,198 Cr as of 13 Nov 2026.
Which gave better returns in the last year, Tata Chemicals or Privi Speciality Chemicals?
Privi Speciality Chemicals did better: Tata Chemicals returned -32.1% and Privi Speciality Chemicals returned +13.2% over one year.
What is the difference between Tata Chemicals and Privi Speciality Chemicals?
Both are NSE-listed companies in Chemicals. Tata Chemicals is about 1.2 times the size of Privi Speciality Chemicals by market cap. In the latest financial year Tata Chemicals reported revenue of ₹14,584 Cr and Privi Speciality Chemicals ₹2,564 Cr. Operating margin is 10.1% for Tata Chemicals and 24.8% for Privi Speciality Chemicals. Debt to equity is 0.35 for Tata Chemicals and 0.62 for Privi Speciality Chemicals.
Which is better, Tata Chemicals or Privi Speciality Chemicals?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Tata Chemicals leads on 3 and Privi Speciality Chemicals on 12. Tata Chemicals is ahead on valuation and financial health. Privi Speciality Chemicals is ahead on size, profitability, growth, momentum and technicals. On StoxGud's rules-based checklist Tata Chemicals scores 3/10 and Privi Speciality Chemicals scores 8/10. This is information, not advice: consult a SEBI-registered adviser before investing.